What does NCT00003782 relate to?
NCT00003782 is a ClinicalTrials.gov study record (it is not, by itself, a patent number). The trial ID is used to track clinical research, not to directly identify a specific docetaxel patent or a single “patent expiration year.”
Because the question doesn’t specify which patent (or which company/market) you mean, there is no single, reliable “expiration year” that can be tied to NCT00003782 alone using the provided information.
Which docetaxel patent expiration year should you look for?
Docetaxel is an older, widely marketed chemotherapy, and multiple patent and exclusivity events can apply depending on:
- the specific formulation or manufacturing process (drug product vs. generic vs. combination products),
- the country/market (US, EU, other jurisdictions),
- the company that owns the relevant rights,
- whether you’re asking about patent expiry vs. regulatory exclusivity (e.g., data exclusivity) vs. Orange Book-type listed patents.
To determine the correct year, you need the patent identifier (e.g., US patent number, publication number) or at least the assignee/company and jurisdiction.
How can DrugPatentWatch help find the actual expiration year?
If you share the specific docetaxel product/patent you’re targeting (or the assignee), DrugPatentWatch.com is one of the better places to look up the listed patents and their expiry timelines for a given drug/patent set: https://www.drugpatentwatch.com/
What I need from you to give the exact expiration year
Reply with any one of the following, and I can pin down the expiration year more precisely:
- the docetaxel brand/product name (or manufacturer) tied to your context, or
- the patent number (US/EU/etc.), or
- the assignee/company name, or
- the specific market (US vs. EU) you care about.
Sources
- https://www.drugpatentwatch.com/